Participations à des congrès et colloques internationaux (35)
15.
Bedard, P. L., Ignatiadis, M., Haibe-Kains, B., Loi, S., Criscitiello, C., Desmedt, C., Bontempi, G., Piccart-Gebhart, M., & Sotiriou, C. (2009). Limited Clinical Utility of Prognostic Gene Expression Profiles in Grade 3 Node-Negative Early Stage Breast Cancer. Poster présenté à la conférence San Antonio Breast Cancer Symposium (December 2009: San Antonio, Tx, USA).16.
Ignatiadis, M., Bedard, P. L., Haibe-Kains, B., Singhal, S., Loi, S., Criscitiello, C., Desmedt, C., Bontempi, G., Piccart-Gebhart, M., & Sotiriou, C. (2009). A Meta-Analysis of Gene Expression Profiling Studies Identifies Clinically Relevant Oncogenic Pathways in Basal-Like Breast Cancer. Poster présenté à la conférence San Antonio Breast Cancer Symposium (December 2009: San Antonio, Tx, USA).19.
Le Mercier, M., Lefranc, F., Haibe-Kains, B., Bontempi, G., Kiss, R., & Mathieu, V. (2008). Galectin-1 involvement in glioma chemoresistance. Poster présenté à la conférence American Association for Cancer Research Annual Meeting (99th: April 12-16: San Diego - USA).20.
Lefranc, F., Spiegl-Kreinecker, S., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Berger, W., & Kiss, R. (2008). Temozolomide displays anti-migratory effects in human glioblastoma cells through neuregulin down-regulation. Poster présenté à la conférence American Association for Cancer Research Annual Meeting (99th: April 12-16: San Diego - USA).22.
Sotiriou, C., Desmedt, C., Haibe-Kains, B., Harris, A., Larsimont, D., Buyse, M., Wirapati, P., Delorenzi, M., Bontempi, G., & Piccart-Gebhart, M. (2007). Biological mechanisms that trigger breast cancer (BC) tumor progresion are molecular subtype dependent. Journal of Clinical Oncology: 2007 ASCO Annual Meeting Proceedings. Vol. Vol 25, (p. 18) Abstract session presented at ASCO(June 2007: Chicago, IL, USA).